Maria F. Brizzi-Felice
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
From molecular engineering to clinical applications: The expanding role of bispecific antibodies in onco-immunology.
Journal: Pharmacological research
Published: September 12, 2025
IL-3/STAT5/miR-155-5p axis supports stem-related pathway reprogramming in TNBC.
Journal: Breast cancer research : BCR
Published: April 21, 2025
Chimeric antigen receptor (CAR) T-cell therapy: Harnessing extracellular vesicles for enhanced efficacy.
Journal: Pharmacological research
Published: June 28, 2024
Correction: Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming.
Journal: Oncogenesis
Published: July 25, 2023
Circulating extracellular vesicles derived from tumor endothelial cells hijack the local and systemic anti-tumor immune response: Role of mTOR/G-CSF pathway.
Journal: Pharmacological research
Published: April 27, 2023
First pilot case-control interventional study using autologous extracellular vesicles to treat chronic venous ulcers unresponsive to conventional treatments.
Journal: Pharmacological research
Published: February 07, 2023
IL-3 signalling in the tumour microenvironment shapes the immune response via tumour endothelial cell-derived extracellular vesicles.
Journal: Pharmacological research
Published: January 24, 2022
Extracellular vesicles from patients with Acute Coronary Syndrome impact on ischemia-reperfusion injury.
Journal: Pharmacological research
Published: April 06, 2021
Type 2 diabetes mellitus and sepsis: state of the art, certainties and missing evidence.
Journal: Acta diabetologica
Published: March 01, 2021
A challenging case of severe ulcerated cutaneous lesion.
Journal: Internal and emergency medicine
Published: February 11, 2021
Should the search for COVID-19 become part of the work-up of incidental thromboembolism? A near-missed COVID-19 diagnosis.
Journal: Internal and emergency medicine
Published: June 23, 2020
Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming.
Journal: Oncogenesis
Published: May 14, 2020
Last Updated: 09/26/2026